OSUR - Utang jangka dawa perusahaan OraSure Technologies Inc

OraSure Technologies (OSUR) generates revenue through the global supply of diagnostic systems for infection detection and genetic collection tools. Business stability relies on the retention of R&D personnel and experts in test production automation. Long-term debt stands at 0.01. The price chart below illustrates the performance of the issuer, which leads the rapid test segment for pharmacies and clinics thanks to unique patents for biomaterial collection.

An analysis of long-term liabilities allows for an assessment of OraSure Technologies (OSUR) resilience to systemic shocks and government contract volatility. Dependence on public procurement and the shift toward at-home testing require a significant buffer to sustain R&D. This metric measures the volume of borrowed capital with a maturity exceeding one year, determining the business's financial leverage. By examining the company's long-term debt history, an investor can determine the balance between over-leverage risks and investment efficiency.